Dr. Rifkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 N Williams St
Ste 200
Denver, CO 80218Phone+1 303-388-4876Fax+1 303-830-8633
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1986 - 1988
- HCA HealthONE/Sky Ridge Medical CenterResidency, Internal Medicine, 1983 - 1986
- University of ColoradoInternship, Internal Medicine, 1982 - 1983
- University of Colorado School of Medicine Anschutz Medical CampusClass of 1982
Certifications & Licensure
- AZ State Medical License 1987 - 2027
- CO State Medical License 1984 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor Start of enrollment: 2004 Mar 01
- Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation Start of enrollment: 2005 Nov 01
- Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant Start of enrollment: 2007 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the ConnectMM Registry.Howard R Terebelo, James Omel, Lynne I Wagner, James W Hardin, Robert M Rifkin
Clinical Lymphoma, Myeloma & Leukemia. 2025-01-01 - 1 citationsReal-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody.Karthik Ramasamy, Ravi Vij, David Kuter, David Cella, Brian G M Durie
Clinical Lymphoma, Myeloma & Leukemia. 2024-12-06 - Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.Sikander Ailawadhi, Hans C Lee, James Omel, Kathleen Toomey, James W Hardin
Blood Cancer Journal. 2024-11-11
Abstracts/Posters
- Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: ...Robert M. Rifkin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Treatment Patterns and Outcomes in Elderly Patients with Newly Diagnosed Multiple Myeloma: Results from the Connect¬ MM RegistryRobert M. Rifkin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloi...Robert M. Rifkin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Long-Term Proteasome Inhibitor (PI) Therapy in Community Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Transitioning from Bortezomib (Btz)-Based to Ixazo...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Initial Data from a Phase 2, Non-Comparative Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Ixazomib Plus Lenalidomide-Dexamethasone (IRd) in Relapsed/Refractory Multiple Myeloma (MM) Patients (Pts) – Effectiveness in Routine Clinical Practice Is Similar to t...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Understanding Multiple Myeloma Treatment Patterns and Sequencing with Robert Rifkin, MD, FACPFebruary 6th, 2023
- CU Strategic Plan: Robust Research Goals AheadSeptember 16th, 2021
- US Oncology Research Announces Schedule of Presentations at the Virtual 2020 American Society of Hematology Annual Meeting and ExpositionDecember 2nd, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: